Therefore, this article describes the known immunobiological functions of the IL-33/ST2 pathway in CAD occurrence and development and also presents a meta-analysis of the IL-33/ST2 gene polymorphisms associated with an increased risk of CAD. The gene discussed is IL1RL1; the disease is coronary artery disorder.